Human Neutrophil Peptide 1 vs Ramoplanin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Human Neutrophil Peptide 1 (HNP-1) is the most abundant alpha-defensin in human neutrophil granules, where it constitutes up to 30% of total protein content. Alpha-defensins HNP-1, -2, -3, and -4 are the human versions of the ancestral defensin family....
Calculate Human Neutrophil Peptide 1 dose →Ramoplanin is a glycodepsipeptide antibiotic produced by Actinoplanes sp. ATCC 33076 with potent activity against gram-positive bacteria....
Calculate Ramoplanin dose →| Parameter | Human Neutrophil Peptide 1 | Ramoplanin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Preclinical | Phase 3 (Discontinued) |
| Half-Life | Hours (in tissues) | Short (gut lumen) |
| Typical Dose | N/A | 200 mg twice daily |
| Frequency | N/A | Twice daily |
| Route | Endogenous (secreted by neutrophils) / Research only | Oral (non-absorbed) |
| FDA Status | Not approved | Not approved (Phase 3 discontinued) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.